Preview

Инфекция и иммунитет

Расширенный поиск

ПАНДЕМИЯ COVID-19: СИСТЕМАТИЧЕСКИЙ ОБЗОР СОВРЕМЕННЫХ ДАННЫХ

https://doi.org/10.15789/2220-7619-TCP-1508

Полный текст:

Аннотация

Эпидемия коронавирусного заболевания 2019г. (COVID-19) началась в декабре 2019г. в Китае и представляет серьезную проблему. Одним из важных очерченных вопросов является ее быстрое распространения во всем мире. В ряде работ были описаны эпидемиология, клинико-лабораторные признаки, рентгенологические характеристики и лечение COVID-19. Однако, в настоящее время в доступной литературе отсутствуют систематические обзоры, описывающие накопленные данные по COVID-19.
Цель: описание эпидемиологии COVID-19, а также клинических особенностей, диагностики и лечения.

Источник данных: проведен систематический обзор литературы по ключевым словам "коронавирус" и "2020", "COVID-19" в базах данных: Science Direct, PubMed, Springer и Scopus за период с января 1 2020г. по 23 февраля 2020г.

Отбор типа исследований: все обсервационные исследования, а также описание клинических случаев и редакционных комментариев на английском языке.

Извлечение данных: различными наблюдателями производилось извлечение данных по методам контроля COVID-19.

Результаты: в результате поиска удалось обнаружить 131 статью. После оценки содержания тезисов и названия статей были отобраны 58 работ для анализа полного текста статей, из которых в обзор включены 43 статьи. COVID-19 быстро распространяется и передается при тесном контакте между людьми через назо- и орофарингеальные аэрозоли. COVID-19 вызывал существенные проблемы особенно у пациентов с сопутствующими заболеваниями и у лиц пожилого возраста. Основными клиническими чертами COVID-19 были лихорадка, кашель, боли в горле и диаррея. Наиболее распространенными рентгенологическим признаками заболевания были вид двустороннего матового стекла. Для этиотропной терапии применялись ЛОПИНАВИР и РИТОНАВИР.

Conclusion: COVID-19 является новым инфекционным заболеванием и представляет серьезную проблему для здравоохранения. Требуется проведение дополнительных исследований для определения факторов, которые могут опосредовать развитие патогенеза тяжелой и фатальной формы заболевания.

Ключевые слова


Об авторах

Р. Гоми
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


Н. Асгари
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


А. Хаджихейдари
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


Р. Эстеки
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


Ф. Бйабанаки
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


Ф. Насиринасаб
Исфаханский Университет медицинских наук, Исфахан, Иран
Иран


Список литературы

1. Gardner L., h.s.j.e.J., date last accessed). Mapping the Wuhan Coronavirus (2019-nCoV). 2020.

2. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19)Situation Report –66. 2020 Data as reported by national authorities by 10:00CET26March 2020].

3. Zhu, Y., et al., The Risk and Prevention of Novel Coronavirus Pneumonia Infections Among Inpatients in Psychiatric Hospitals. Neuroscience Bulletin, 2020: p. 1-4.

4. Chen, Y., Q. Liu, and D. Guo, Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology, 2020.

5. Peeri, N.C., et al., The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? International journal of epidemiology, 2020.

6. Herna´ndez JC and Austin Ramzy T. China Confirms New Coronavirus Spreads from Humans to Humans. 2020 24 January 2020, date last accessed].

7. de Wit, E., et al., SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology, 2016. 14(8): p. 523.

8. Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506.

9. Elizabeth Cohen C. CDC to Screen at three US Airports for Signs of New Virus from China. 2020 (30 January 2020, date last accessed).].

10. Chan, J.F.-W., et al., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 2020. 395(10223): p. 514-523.

11. Chen, N., et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 2020. 395(10223): p. 507-513.

12. Bonilla-Aldana, D.K., et al., SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses?–A bibliometric analysis. Travel medicine and infectious disease, 2020. 33: p. 101566.

13. Al-Tawfiq, J.A., A. Zumla, and Z.A. Memish, Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel medicine and infectious disease, 2014. 12(5): p. 422-428.

14. Moher D, et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009. 6.

15. Zhang, Y., et al., A novel coronavirus (COVID-19) outbreak: a call for action. Chest, 2020.

16. Lim, J., et al., Case of the index patient who caused tertiary transmission of Coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. Journal of Korean Medical Science, 2020. 35(6).

17. Tong, Z., et al., Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerging infectious diseases, 2020. 26(5).

18. Guan, W.-j., et al., Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 2020.

19. Yang, Y., W. Shang, and X. Rao, Facing the COVID‐19 outbreak: What should we know and what could we do? Journal of Medical Virology, 2020.

20. Lin, C., et al., Asymptomatic novel coronavirus pneumonia patient outside WuHan: The value of CT images in the course of the disease. Clinical Imaging, 2020.

21. Cheng, Z.J. and J. Shan, 2019 Novel coronavirus: where we are and what we know. Infection, 2020: p. 1-9.

22. Song, P. and T. Karako, COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern. BioScience Trends, 2020.

23. Lai, C.-C., et al., Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents, 2020: p. 105924.

24. Sabino-Silva, R., A.C.G. Jardim, and W.L. Siqueira, Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clinical Oral Investigations, 2020: p. 1-3.

25. Lin, X., et al., Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean Journal of Radiology, 2020. 21(3): p. 365-368.

26. Jalava, K., First respiratory transmitted food borne outbreak? International Journal of Hygiene and Environmental Health, 2020. 226: p. 113490.

27. Gostic, K., et al., Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife, 2020. 9.

28. Chen, X., et al., Initiation of a new infection control system for the COVID-19 outbreak. The Lancet Infectious Diseases, 2020.

29. Lum, L.H.W. and P.A. Tambyah, Outbreak of COVID-19–an urgent need for good science to silence our fears? Singapore Medical Journal, 2020. 61(2): p. 55.

30. Yang, X., et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 2020.

31. Qiao, J., What are the risks of COVID-19 infection in pregnant women? The Lancet, 2020.

32. Albarello, F., et al., 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. International Journal of Infectious Diseases, 2020.

33. MacLaren, G., D. Fisher, and D. Brodie, Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. JAMA, 2020.

34. Velavan, T.P. and C.G. Meyer, The COVID‐19 epidemic. Tropical Medicine & International Health, 2020.

35. Wong, J.E., Y.S. Leo, and C.C. Tan, COVID-19 in Singapore—Current Experience: Critical Global Issues That Require Attention and Action. JAMA, 2020.

36. Zhang, J.j., et al., Clinical characteristics of 140 patients infected by SARS‐CoV‐2 in Wuhan, China. Allergy, 2020.

37. Chen, H., et al., Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 2020.

38. Tian, S., et al., Characteristics of COVID-19 infection in Beijing. Journal of Infection, 2020.

39. Van Cuong, L., et al., The first Vietnamese case of COVID-19 acquired from China. The Lancet. Infectious diseases, 2020.

40. Team, C.-N.I.R.S., COVID-19, Australia: Epidemiology Report 2 (Reporting week ending 19:00 AEDT 8 February 2020). Communicable diseases intelligence (2018), 2020. 44.

41. Guarner, J., Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19. 2020, Oxford University Press US.

42. Xu, Z., et al., Full spectrum of COVID-19 severity still being depicted. The Lancet, 2020.

43. Xu, Y.-H., et al., Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2. Journal of Infection, 2020.

44. Wu, J., et al., Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Investigative radiology, 2020. 55(5): p. 257-261.

45. Habibzadeh, P. and E.K. Stoneman, The Novel Coronavirus: A Bird's Eye View. The international journal of occupational and environmental medicine, 2020. 11(2): p. 65.

46. Qin, C., et al., 18 F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases. European Journal of Nuclear Medicine and Molecular Imaging, 2020: p. 1-6.

47. The, L., COVID-19: fighting panic with information. Lancet (London, England), 2020. 395(10224): p. 537.

48. Kim, J.Y., et al., Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea. Journal of Korean Medical Science, 2019. 35(7).

49. Bai, Y., et al., Presumed asymptomatic carrier transmission of COVID-19. Jama, 2020.

50. Kim, H., Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? 2020, Springer.

51. Pan, Y. and H. Guan, Imaging changes in patients with 2019-nCov. 2020, Springer.

52. Wu, C., et al., Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 2020.

53. Gao, J., Z. Tian, and X. Yang, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends, 2020.

54. Liu, S., et al., Online mental health services in China during the COVID-19 outbreak. The Lancet Psychiatry, 2020.

55. Chen, Q., et al., Mental health care for medical staff in China during the COVID-19 outbreak. The Lancet Psychiatry, 2020.

56. Yang, Y., et al., Mental health services for older adults in China during the COVID-19 outbreak. The Lancet Psychiatry, 2020. 7(4): p. e19.

57. Liem, A., et al., The neglected health of international migrant workers in the COVID-19 epidemic. The Lancet Psychiatry, 2020.

58. Wu, J.T., K. Leung, and G.M. Leung, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet, 2020. 395(10225): p. 689-697.

59. Chan‐Yeung, M. and R.H. Xu, SARS: epidemiology. Respirology, 2003. 8: p. S9-S14.

60. Centers for Disease Control and Prevention C. 2019 Novel Coronavirus (2019-nCoV). 2020.

61. Srikantiah, P., et al., SARS clinical features, United States, 2003. Emerging infectious diseases, 2005. 11(1): p. 135.

62. Nassar, M., et al., Middle East respiratory syndrome coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. European review for medical and pharmacological sciences, 2018. 22(15): p. 4956-4961.

63. Yin, Y. and R.G. Wunderink, MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 2018. 23(2): p. 130-137.

64. de Groot, R.J., et al., Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. Journal of virology, 2013. 87(14): p. 7790-7792.

65. Zhang, S., et al., Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. International Journal of Infectious Diseases, 2020. 93: p. 201-204.

66. Wang, C., et al., A novel coronavirus outbreak of global health concern. The Lancet, 2020. 395(10223): p. 470-473.

67. Lee, N., et al., A major outbreak of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine, 2003. 348(20): p. 1986-1994.

68. Tsang, K.W., et al., A cluster of cases of severe acute respiratory syndrome in Hong Kong. New England Journal of Medicine, 2003. 348(20): p. 1977-1985.

69. Rivers, C.M., M.S. Majumder, and E.T. Lofgren, Risks of death and severe disease in patients with Middle East respiratory syndrome coronavirus, 2012–2015. American Journal of Epidemiology, 2016. 184(6): p. 460-464.

70. Assiri, A., et al., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases, 2013. 13(9): p. 752-761.

71. Arabi, Y.M., et al., Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials, 2018. 19(1): p. 81.

72. Chu, C., et al., Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 2004. 59(3): p. 252-256.

73. Sheahan, T.P., et al., Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Science translational medicine, 2017. 9(396).

74. Sheahan, T.P., et al., Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 2020. 11(1): p. 1-14.


Для цитирования:


Гоми Р., Асгари Н., Хаджихейдари А., Эстеки Р., Бйабанаки Ф., Насиринасаб Ф. ПАНДЕМИЯ COVID-19: СИСТЕМАТИЧЕСКИЙ ОБЗОР СОВРЕМЕННЫХ ДАННЫХ. Инфекция и иммунитет. 2020;. https://doi.org/10.15789/2220-7619-TCP-1508

For citation:


Ghomi R., Asgari N., Hajiheydari A., Esteki R., Biyabanaki F., Nasirinasab F. THE COVID-19 PANDEMIC: A SYSTEMATIC REVIEW OF THE CURRENT EVIDENCE. Russian Journal of Infection and Immunity. 2020;. https://doi.org/10.15789/2220-7619-TCP-1508

Просмотров: 94


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2220-7619 (Print)
ISSN 2313-7398 (Online)